DeviceTalks Podcast Network

In this episode of the DeviceTalks Weekly Podcast, SetPoint Medical CEO Murthy Simhambhatla gives listeners an audio glimpse of what attendees at DeviceTalks Minnesota will hear during the Bringing NeuroTechnologies to New Markets panel.

As he explains in this interview, Simhambhatla—an experienced MedTech executive—was initially skeptical of SetPoint’s potential after being invited to lead the company. But the more he read, the more he became convinced the vagal stimulator could help fight inflammation. “Cytokines don’t lie,” he said. Today, SetPoint Medical has FDA approval, is building a commercial plan, and is considering future financing, including a possible IPO.

This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to see the agenda. Remember to use the code DTM25 to save 25% on new registrations.

We also get a visit to our FOMO Studios from Saul Marquez, CEO of Outcome Rocket, a market research and end-to-end marketing execution agency that helps medtech and health tech organizations grow their impact and accelerate growth. See more and download the report we discuss here: https://www.outcomesrocket.com/

Finally, MassDevice Editor Chris Newmarker shares this week’s top newsmakers from MassDevice—Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Pulnovo, and CathWorks.

***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:09:23) - 5 next-gen heart valve replacement companies you need to know
(00:11:35) - Abbott completes enrollment in IVL study
(00:13:50) - Johnson & Johnson MedTech to launch new AI module for EP mapping
(00:15:10) - Johnson & Johnson MedTech to launch new AI module for EP mapping
(00:17:12) - Medtronic leads $100M financing for artery denervation tech developer Pulnovo Medical
(00:23:34) - FOMO Studio: Saul Marquez, CEO, Outcomes Rocket
(00:38:19) - Keynote Conversation: SetPoint Medical CEO Murthy Simhambhatla

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Michael Carter, SVP, President, Cranial & Spinal Technologies about the company’s deployment of robotics, AI and other tech.

Managing Editor Kayleen Brown hosts Etienne Nichols, Head of Industry Insights & Education, Greenlight Guru, on this weeks’ FOMO.

MassDevice Editor Chris Newmarker highlights the MassDevice newsmakers – Stereotaxis, Robocath, Prosomnus, Johnson & Johnson MedTech, Avanos Medical, Stryker and Amplitude Vascular Systems.

Thanks to Greenlight Guru for sitting in our FOMO studio! Download its QMSR readiness playbook, it's everything you need to get compliant with QMSR, all in one place:
https://www.greenlight.guru/qmsr-readiness-playbook-free-download

If you haven’t registered for DeviceTalks Minnesota or DeviceTalks Boston, use the code DTW25 to save 25%

***
Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe 

Chapters

(00:01:25) - Discount Code for DeviceTalks events
(00:03:11) - MassDevices' Newmarker's Newsmakers
(00:05:25) - Stereotaxis to acquire Robocath for up to $45M
(00:09:02) - ProSomnus gets FDA nod for latest sleep apnea therapy device
(00:12:08) - - Johnson & Johnson ups 2026 outlook on Q1 beats, MedTech sales rise 7.7%
(00:15:11) - Avanos Medical agrees to be acquired by private equity firm in $1.3B deal
(00:16:22) - Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems
(00:18:06) - FOMO Guest: Etienne Nichols, Head of Industry Insights & Education, Greenlight Guru
(00:31:55) - Keynote Interview- Michael Carter, SVP President, Cranial & Spinal Technologies, Medtronic

In this episode of the DeviceTalks Women in MedTech podcast, Host Kayleen Brown sits down with Gaele Lalahy, Chief Operating Officer at Plexāā, to discuss what it looks like to treat patients as true co-designers, not only in product development but across the entire pre-surgery experience.

Lalahy shares the clinical foundation behind BLOOM⁴³, Plexāā’s wearable, at-home device used the night before breast surgery to increase blood flow and support healing through supraphysiological preconditioning, and explains how Plexāā pairs the device with a holistic app that helps patients feel prepared, informed, and supported before and after surgery.

Kayleen also welcomes Tom Salemi, Editorial Director of DeviceTalks, for an in-studio conversation that connects the episode’s theme to the broader MedTech ecosystem, including a look ahead at DeviceTalks Minnesota, May 4 and DeviceTalks Boston, May 27–28. Together, they discuss how listening to the end user shapes better outcomes, better experiences, and better leadership.

* Mentioned in the interview * Check out this DeviceTalks Weekly episode featuring Samay's CEO Maria Artunduaga: https://www.devicetalks.com/how-samays-ceo-came-up-with-the-sound-idea-for-a-device-to-battle-copd-win-medtech-innovator/

***

Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players: https://women-in-medtech.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:00:08) - Intro to theme: patient as co‑designer
(00:03:38) - Interview with In-Studio guest, Tom Salemi
(00:04:29) - DeviceTalks Minnesota (May 4) & DeviceTalks Boston (May 27–28) preview
(00:14:17) - Keynote interview with Gaele Lalahy, COO, Plexāā
(00:15:59) - Gaele’s origin story: gymnast mindset, Panasonic, and “unlearning” into MedTech
(00:26:50) - Plexāā + BLOOM⁴³ explained: reducing complications with supraphysiological preconditioning
(00:39:55) - Leadership + allyship: building teams, saying yes, and mentor shout-outs

In this episode of the DeviceTalks Weekly Podcast, OrthAlign CEO Eric Timko explains how he’s built two successful companies in the wake of surgical robotics’ rise in orthopedics. He also shares sage advice from his father—words that ultimately led him to a career in medical devices.

This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off registration.

In this week’s Newmarker’s Newsmakers, Host Tom Salemi shares his experience from MedTech Innovator’s Radar Forum. Then he and Chris Newmarker review the biggest news on MassDevice: Stryker, Johnson & Johnson MedTech, Intuitive, Baxter, and the Transcatheter Heart Valves Special Report.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:02:30) - MedTech Innovator Radar Forum
(00:09:30) - MassDevice’s Transcatheter Heart Valves Special Report
(00:11:08) - Stryker operations fully restored after cyberattack
(00:14:55) - Johnson & Johnson brings next-gen Varipulse PFA catheter to Europe
(00:16:30) - Former Intuitive EVP Brian Miller joins Sovato as CEO
(00:21:18) - Former Baxter CEO takes the corner office at Hologic as go-private deal closes
(00:26:20) - Keynote interview: Eric Timko, CEO, OrthAlign

In this episode of the DeviceTalks Weekly podcast, Amaza Reitmeier shares with Host Tom Salemi why she left the company she never thought she’d leave — Medtronic — to lead Pharaoh Neuro, a company developing a novel approach to treating stroke patients by removing harmful blood from cerebrospinal fluid. Reitmeier shares lessons from her own career and her mentors on timing big moves, learning what you don’t know, and why some of MedTech’s biggest opportunities remain hidden in plain sight.

This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off the registration fee.

Salemi and MassDevice Editor Chris Newmarker offer encouragement to exercising listeners while delivering this week’s Newmarker’s Newsmakers — including updates on cardiology companies, HistoSonics, Boston Scientific, Johnson & Johnson MedTech, Abbott, the Mayo Clinic, and WHOOP.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:08:12) - The biggest cardiology tech stories out of ACC 2026
(00:11:45) - HistoSonics kicks off study using Edison histotripsy system in BPH
(00:14:20) - Boston Scientific completes Valencia Technologies acquisition
(00:16:00) - Johnson & Johnson MedTech shares findings for Impella CP in left ventricle support
(00:16:27) - Abbott joins $575M funding round for wearable maker WHOOP
(00:22:20) - Keynote Interview, Amaza Reitmeier, CEO, Pharaoh Neuro